Breaking News Instant updates and real-time market news.

MCD

McDonald's

$199.20

-0.71 (-0.36%)

, GOOGL

Alphabet Class A

$1,168.28

-15.39 (-1.30%)

19:26
05/19/19
05/19
19:26
05/19/19
19:26

Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Alphabet's Google (GOOG; GOOGL) has suspended business with Huawei that requires the transfer of hardware and software products except those covered by open source licenses in a blow to the Chinese technology company that the U.S. government has sought to blacklist around the world, according to Reuters, citing a source familiar with the matter. Huawei Technologies will immediately lose access to updates to the Android operating system, and the next version of its smartphones outside of China will also lose access to popular applications and services including the Google Play Store and Gmail app, the report noted. 2. African swine fever, harmless to humans but deadly to pigs, has decimated Chinese hog counts, constraining supplies in the world's top market for pork, and McDonald's (MCD) and Tyson (TSN) are among companies that expect tighter supplies of pork and bacon to result in more-expensive meat globally, The Wall Street Journal's Heather Haddon and Jacob Bunge reported. 3. Nordstrom (JWN) remains the best-positioned retailer in the tough department store sector, with a mix of full-price and discount stores, a pioneering online presence and a reputation for superior service and affluent customers, Andrew Bary wrote in this week's edition of Barron's. Investor worries include a disappointing Christmas selling season and potential tariffs on Chinese-made clothing and shoes, but that seems already discounted in the stock, the author noted, adding that Nordstrom's generous dividend looks secure, given that the company pays outs just 40% of its earnings. 4. Disney (DIS) and Marvel's "Avengers: Endgame" reign has come to an end after three weekends at the top of the domestic box office. Winning the weekend, Lionsgate's (LGF.A) "John Wick: Chapter Three - Parabellum" earned $57.2M in its debut from 3,850 theaters. The movie sports an A- CinemaScore and an 88% Rotten Tomatoes score. Overseas, "Parabellum" earned $35.2M from 66 international markets. 5. Applied Materials (AMAT), BorgWarner (BWA), Charles Schwab (SCHW), Regeneron Pharmaceuticals (REGN), Tapestry (TPR) and Take-Two (TTWO) saw positive mentions in this week's edition of Barron's.

MCD

McDonald's

$199.20

-0.71 (-0.36%)

GOOGL

Alphabet Class A

$1,168.28

-15.39 (-1.30%)

GOOG

Alphabet

$1,161.89

-16.89 (-1.43%)

TSN

Tyson Foods

$82.50

-0.48 (-0.58%)

JWN

Nordstrom

$37.09

0.16 (0.43%)

DIS

Disney

$135.04

-0.46 (-0.34%)

LGF.A

Lionsgate

$15.60

1.99 (14.62%)

AMAT

Applied Materials

$42.72

-1.56 (-3.52%)

BWA

BorgWarner

$36.27

-0.375 (-1.02%)

SCHW

Charles Schwab

$43.21

-0.94 (-2.13%)

REGN

Regeneron

$304.81

-4.69 (-1.52%)

TPR

Tapestry

$30.78

-0.56 (-1.79%)

TTWO

Take-Two

$106.76

-0.81 (-0.75%)

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 29

    May

  • 31

    May

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 14

    Jun

  • 19

    Jun

  • 19

    Jun

  • 25

    Jun

  • 26

    Jun

  • 25

    Jul

  • 27

    Oct

  • 13

    Nov

MCD McDonald's
$199.20

-0.71 (-0.36%)

05/01/19
BTIG
05/01/19
NO CHANGE
Target $220
BTIG
Buy
McDonald's price target raised to $220 from $200 at BTIG
BTIG analyst Peter Saleh raised his price target on McDonald's to $220 and kept his Buy rating after its Q1 results, saying the company's menu strategy shift has boosted comps. The analyst expects the increased menu focus on "bundles and full price items" - away from deep discounts - to drive higher U.S. average check for the next couple of quarters. Saleh adds that he is "encouraged by the direction of franchisee cash flow" in spite of his disappointment over negative traffic trends.
05/01/19
05/01/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. McDonald's (MCD) downgraded to Neutral from Buy at Longbow with analyst Alton Stump saying while the company's "impressive" U.S. comp growth in Q1 increases his confidence in comps over the last three quarters of the year, he also believes the stock reflects his favorable view with shares trading near his prior price target of $200. 2. Sabre (SABR) downgraded to Market Perform from Outperform at William Blair with analyst Matthew Pfau saying that while the company outperformed in Q1, it lowered guidance across all headline metrics. 3. Alkermes (ALKS) downgraded to Neutral from Buy at Citi with analyst Liav Abraham saying while the positive Phase 3 data for ALKS 3831 in Q4 support a constructive view on the compound, there are not "sufficient meaningful catalysts to drive material upside" in the stock for the remainder of 2019. 4. Tile Shop (TTS) downgraded to Neutral from Buy at Citi with analyst Geoffrey Small saying the company's turnaround "showed encouraging progress" in the second half of 2018, but the Q1 results "represented a sizeable step back." 5. Cummins (CMI) downgraded to Hold from Buy at Loop Capital with analyst Jeffrey Kauffman saying he believes good news is mostly priced into the shares at current valuation levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/01/19
LBOW
05/01/19
DOWNGRADE
LBOW
Neutral
McDonald's downgraded to Neutral on valuation at Longbow
As previously reported, Longbow analyst Alton Stump downgraded McDonald's (MCD) to Neutral from Buy. While the company's "impressive" U.S. comp growth in Q1 increases his confidence in comps over the last three quarters of the year, he also believes the stock reflects his favorable view with shares trading near his prior price target of $200. Stump added that he believes the strong U.S. comparable sales growth likely means the company gained share from the likes of Dunkin' Brands (DNKN), Burger King (QSR) and Wendy's (WEN) in Q1.
05/01/19
RHCO
05/01/19
NO CHANGE
Target $230
RHCO
Buy
McDonald's price target raised to $230 from $200 at SunTrust
SunTrust analyst Jake Bartlett raised his price target on McDonald's to $230 and kept his Buy rating after its Q1 results, saying the stock should see continued upside given its "broad-based SSS strength." The analyst also raises his FY19 U.S. comps forecast to 4.5% from 3.5% - the strongest since 2011 - with a positive view on the company's delivery and menu innovation initiatives.
GOOGL Alphabet Class A
$1,168.28

-15.39 (-1.30%)

05/17/19
BARD
05/17/19
NO CHANGE
BARD
Sony, Microsoft JV a 'surprsing turn' in 'battle for living room,' says Baird
Baird analyst Colin Sebastian said he views the joint venture pact between competitors Microsoft (MSFT) and Sony (SNE) on cloud-based gaming services as both "surprising" and a validation of the emerging market for streaming. The two companies clearly view video games as strategically important enough to put aside their intense competition and see Google (GOOGL) as a legitimate competitor and the Stadia streaming platform as a credible threat, said Sebastian, who added that he does not believe this means Sony and Microsoft will forego their separate console hardware platforms. He also believes that video game developers and publishers should benefit from the intensifying battle among platform companies for share of the game market and the "living room audience." Publicly traded game makers include Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two (TTWO).
05/17/19
CHLM
05/17/19
DOWNGRADE
CHLM
Hold
Craig-Hallum downgrades Cray to Hold, but says bidding war possible
Craig-Hallum analyst Chad Bennett downgrade Cray (CRAY) to Hold from Buy after the company announced a deal to be acquired by HP Enterprise (HPE) for $35 per share, but he added that he thinks a bidding war is possible since he doesn't believe the stock buyout price "has even begun to value" Cray's proprietary interconnect technology and its modular software stack for next generation AI/ML workloads. He believes there could be a number of interested parties in Cray including Microsoft (MSFT), Dell (DELL), Intel (INTC), Google (GOOG), Amazon (AMZN) and potentially IBM (IBM).
05/15/19
FBCO
05/15/19
NO CHANGE
Target $1400
FBCO
Outperform
Credit Suisse incrementally more positive on Alphabet's 2020 growth prospects
Credit Suisse analyst Stephen Ju attended Google's annual advertiser conference Marketing Live and came away with an "incrementally more positive" viewpoint for revenue growth prospects for 2020 and beyond. The analyst reiterates an Outperform rating and a $1,400 price target on the shares given ongoing monetization improvements in Search through product updates, larger-than-expected contribution from Google's larger non-Search businesses, and optionality for value creation from new monetization initiatives such as Maps and the eventual commercialization of Other Bets.
05/16/19
JPMS
05/16/19
NO CHANGE
Target $365
JPMS
Overweight
Google beta of AI hardware platform positive for Broadcom, says JPMorgan
Google (GOOG, GOOGL) last week at its developer's conference announced that it is offering its flagship artificial intelligence/deep learning hardware platform, called TPU, to the public in beta, JPMorgan analyst Harlan Sur tells investors in a research note. The analyst views the announcement as positive for Broadcom (AVGO) as he believes the company has co-developed all three generations of Google's TPU AI processor customer chips. Further, Sur thinks Broadcom has also won Google's next generation TPU 4.0 processor chip design, which he believes is targeted for ramp in 2021. In addition, the analyst adds that Broadcom has less than 2% total revenue exposure to Huawei. Sur reiterates an Overweight rating on Broadcom with a $365 price target.
GOOG Alphabet
$1,161.89

-16.89 (-1.43%)

05/15/19
DBAB
05/15/19
NO CHANGE
Target $1400
DBAB
Buy
Alphabet price target raised to $1,400 from $1,300 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Alphabet (GOOG) to $1,400 from $1,300 and keeps a Buy rating on the shares. The analyst also increased his estimates to reflect confidence in its medium- term outlook coming out of the Google Marketing Live keynote in San Francisco. He sees an accelerating pace of new advertising product, which makes him "meaningfully more confident" in Alphabet's 2020 outlook. The company has among the best ad product pipelines since the addition of the third paid link in mobile in 2015, Walmsley tells investors in a research note.
TSN Tyson Foods
$82.50

-0.48 (-0.58%)

05/14/19
ARGS
05/14/19
UPGRADE
ARGS
Buy
Tyson Foods upgraded to Buy from Hold at Argus
05/14/19
05/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tyson Foods (TSN) upgraded to Outperform from Neutral at Credit Suisse and to Buy from Hold at Argus. 2. Coca-Cola (KO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying the company's growth outlook is "clearly superior" relative to the packaged goods space, but this is not reflected in the current share price. 3. Capital One (COF) upgraded to Buy from Hold at Jefferies with analyst John Hecht saying he expects the stock to benefit from "bigger payouts and improving efficiencies." 4. Deckers Brands (DECK) upgraded to Positive from Neutral at Susquehanna. 5. Agco (AGCO) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying given Agco's limited exposure to the U.S. row crop sector, the recent sell-off in the shares is overdone. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/14/19
ARGS
05/14/19
UPGRADE
ARGS
Buy
Tyson Foods upgraded to Buy from Hold at Argus
Argus analyst John Staszak upgraded Tyson Foods to Buy with a price target of $92, also raising his FY19 EPS view by 10c to $6.20 and his FY20 target by 25c to $6.75. The analyst contends that the "growing demand for proteins" is positive for the company and other meat processors, with Tyson's beef division seeing an "especially strong demand". Staszak further cites the company's efforts to increase sales of prepared foods to meet the "steady demand and strong margins" while noting the 12.8-times forward earnings multiple on Tyson Foods stock, which is below the average large-cap food processor multiple of 18.4-times and in the lower half of its historical 9- to 19-times range.
05/14/19
05/14/19
UPGRADE
Target $96

Outperform
Tyson Foods upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Robert Moskow upgraded Tyson Foods to Outperform from Neutral and raised his price target on the shares to $96 from $74. The analyst notes that consensus estimates already factor in stronger Chicken margins based on a rebound in the U.S. supply-demand cycle domestically. However, he does not think they fully account for the upside to chicken, beef, and pork prices from the outbreak of African Swine Fever.
JWN Nordstrom
$37.09

0.16 (0.43%)

05/09/19
WEDB
05/09/19
DOWNGRADE
Target $40
WEDB
Neutral
Nordstrom downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Jennifer Redding downgraded Nordstrom to Neutral from Outperform and lowered her price target for the shares to $40 from $65.
04/10/19
KEYB
04/10/19
UPGRADE
KEYB
Overweight
KeyBanc upgrades Nordstrom to Overweight with $55 price target
KeyBanc analyst Edward Yruma upgraded Nordstrom to Overweight from Sector Weight with a price target of $55. Recent meetings with co-CEO Erik Nordstrom and CFO Anne Bramman affirm that the company is prepared to transition its asset base as e-commerce continues to grow, Yruma tells investors in a research note. The analyst believes Nordstrom is in "two fundamentally attractive sectors of softlines retail: premium and off-price." He believes the current valuation does not reflect the valuation of Nordstrom's e-commerce and Rack assets. Demand weakness as transient and the shares are attractively valued, says Yruma.
05/09/19
05/09/19
DOWNGRADE
Target $40

Neutral
Nordstrom downgraded to Neutral on 'limited room to run' at Wedbush
As previously reported, Wedbush analyst Jen Redding downgraded Nordstrom to Neutral from Outperform based on her belief that shares continue trade near 52-week lows for the foreseeable future. While she likes shares of Nordstrom over the long-term for deep value investors, her proprietary data shows no reason for shares to run in the near-term. Transaction Data signals revenue deterioration and alarming discount trends, although her Promo Tracker signals weakness in merchandise margin, with incremental promotions in April indicating a weak exit to the quarter, she adds. The analyst also lowered her price target for Nordstrom to $40 from $65
04/10/19
04/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. First Solar (FSLR) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Brian Lee citing his view on two potential company-specific catalysts. 2. Disney (DIS) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying with tomorrow's investor day, two Star Wars-themed lands opening in the domestic parks this summer, the launch of streaming service Disney+ before year-end, and a potential re-start of the buyback program within 12 months, Disney shares now have catalysts to go along with downside protection. 3. Under Armour (UA, UAA) assumed with a Buy from Neutral at Citi with analyst Paul Lejuez saying Under Armour is "growing up" with a renewed focus on driving profitability and return on invested capital. 4. KB Home (KBH) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the ongoing shift towards smaller-sized first-time product and double-digit community count growth should drive "above average fundamentals" in fiscal 2019 for KB Home. 5. Nordstrom (JWN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Edward Yruma saying recent meetings with co-CEO Erik Nordstrom and CFO Anne Bramman affirm that the company is prepared to transition its asset base as e-commerce continues to grow. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DIS Disney
$135.04

-0.46 (-0.34%)

05/13/19
PIPR
05/13/19
NO CHANGE
Target $440
PIPR
Overweight
Piper survey shows limited risk to Netflix from Disney streaming service
Piper Jaffray asked 1,536 U.S. Netflix (NFLX) subscribers if they would subscribe to both Disney's (DIS) new streaming service and Netflix, only Netflix or only Disney+, analyst Michael Olson tells investors in a research note. Piper indicated that the Disney+ price point is $7 per month, which it believes will prove to be only an introductory price. The results show that 73% of U.S. Netflix subscribers do not expect to subscribe to Disney+, 20% expect to subscribe to both services, and only 7% indicated that they will cancel Netflix and subscribe to Disney+, Olson tells investors in a research note. The results suggest Netflix's risk of share loss is limited to a small percentage of its base, concludes the analyst. As such, he expects Netflix to continue to "capture a significant portion of the tidal wave of traditional content dollars that are migrating to streaming." Olson maintains an Overweight rating on Netflix shares with a $440 price target. The stock closed Friday down $1.71 to $361.04.
05/09/19
JPMS
05/09/19
NO CHANGE
Target $150
JPMS
Overweight
Disney continues to deliver in every segment, says JPMorgan
JPMorgan analyst Alexia Quadrani reiterates an Overweight rating on Disney with a $150 price target following last night's "strong" quarter. The company's upside to revenue and profits was driven by the core business, which has largely been overshadowed in recent months in anticipation of the Disney+ unveiling, Quadrani tells investors in a post-earnings research note. She believes Disney continues to deliver in every segment, with notable upside this quarter at the Parks. However, the stock may remain range bound near term following the recent run as near-term estimates fluctuate given the lack of clarity around Fox's financial contribution, says the analyst. Nonetheless, she believes Disney shares have the potential to further re-rate in the longer term.
05/15/19
MSCO
05/15/19
NO CHANGE
MSCO
Overweight
Disney will have 'high class problem' if it has to pay more for Hulu, says Morgan Stanley
After Disney (DIS) and Comcast (CMCSA) announced a new agreement regarding their Hulu joint venture, Morgan Stanley analyst Benjamin Swinburne said the new pact is indicative of the priorities of both companies. Operational control of Hulu give Disney a chance to bundle the service with Disney Plus and/or ESPN Plus, allows for international expansion and likely creates some cost synergies, said Swinburne, who added that Disney will have "a high class problem" if it turns out if Hulu is appraised at a higher value when it comes time to buy out Comcast. For Comcast, the new deal gives it downside protection and content flexibility as it builds out its own streaming plans, the analyst added. He keeps Overweight ratings on both Disney and Comcast, concluding that the deal between the media giants will accelerate the transition from legacy TV to streaming.
05/09/19
FBCO
05/09/19
NO CHANGE
Target $130
FBCO
Neutral
Disney price target raised to $130 from $114 at Credit Suisse
Credit Suisse analyst Douglas Mitchelson raised his price target for Disney to $130 from $114 as he believes adding Fox is accretive to long-term value, increasing terminal growth to 3% from 2%, and rolling his target forward one year to 2019. The analyst reiterates a Neutral rating on the shares.
LGF.A Lionsgate
$15.60

1.99 (14.62%)

02/11/19
BRRR
02/11/19
NO CHANGE
Target $21
BRRR
Outperform
Lionsgate price target lowered to $21 from $27 at Barrington
Barrington analyst James Goss lowered his price target for Lionsgate to $21 and keeps an Outperform rating on the shares. The company's content investments have been important in "dramatically" reducing churn following the conclusion of its premiere series Power, Goss tells investors in a research note. This, along with promotional efforts, enabled subscriber levels to remain sequentially flat in Q3, compared to a 500,000 sequential decline in the year-ago period, the analyst points out. His new price target reflects a target multiple of about 10 times his fiscal 2020 OIBDA estimates.
01/14/19
WEDB
01/14/19
NO CHANGE
Target $200
WEDB
Outperform
China price cuts, content M&A to lay groundwork for Apple's future, says Wedbush
Wedbush analyst Daniel Ives believes Apple (AAPL) needs to aggressively cut prices in China on XR and pull forward what he estimates is roughly 15M-20M iPhones that would otherwise sit idle waiting for the next release, or worst case, move to lower priced competition. Additionally, with services the linchpin of the Apple story moving forward, there needs to be serious contemplation within Cupertino around significant content acquisitions to drive services over the coming years, he contends. Ives sees A24, Lionsgate (LGF.A; LGF.B), and Sony Pictures (SNE) among the highest probability M&A targets, Viacom (VIA;VIAB)/CBS(CBS), and MGM Studios among the medium probability M&A targets, and Netflix (NFLX), Disney (DIS), and Gaming platform/video game publishers among the low probability M&A targets. The analyst reiterates an Outperform rating and $200 price target on Apple shares.
04/29/19
IMPC
04/29/19
DOWNGRADE
Target $16
IMPC
In-Line
Lionsgate downgraded to In-Line from Outperform at Imperial Capital
Imperial Capital analyst David Miller downgraded Lionsgate (LGF.B) to In-Line from Outperform and cut his price target for the shares to $16 from $24. The shares closed Friday up 17c to $14.37. The analyst decreased his fiscal 2019 EBITDA and earnings estimates due to additional promotional expenses related to the Starz international rollout. Further, he lowered his 2020 estimates due to concerns that Lionsgate may guide down, due in large part to recent film performance. Due to the disappointing performance of Hellboy in the theatrical window, and "lukewarm" reviews thus far for Long Shot, the Seth Rogan comedy to be released on May 3, there is a "fairly decent chance" Lionsgate may end up falling short of its guidance, Miller tells investors in a research note.
04/29/19
04/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lionsgate (LGF, LGF.A, LGF.B) downgraded to In-Line from Outperform at Imperial Capital with analyst David Miller citing additional promotional expenses related to the Starz international rollout. 2. Occidental Petroleum (OXY) downgraded to Hold from Buy at Jefferies with analyst Jason Gammel saying the company's hostile counter-offer for Anadarko (APC) is a "risky but perhaps necessary move against a better-capitalized bidder for a company that rejected its initial overtures." 3. CVS Health (CVS) downgraded to Neutral from Outperform at Credit Suisse with analyst A.J. Rice saying the stock faces a transitional year as it tries to drive seismic changes in healthcare. 4. Intel (INTC) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the company's Q1 earnings miss and reduced FY19 outlook that reflected the company's Data Center Group weakness, which he calls "the linchpin of growth." 5. 3M (MMM) downgraded to Hold from Buy at Gordon Haskett with analyst John Inch downgraded saying his concerns extend beyond the company's Q1 earnings miss and steep guidance reduction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AMAT Applied Materials
$42.72

-1.56 (-3.52%)

05/17/19
RILY
05/17/19
UPGRADE
Target $54
RILY
Buy
Applied Materials upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Craig Ellis upgraded Applied Materials to Buy from Neutral and raised his price target for the shares to $54 from $46. Signs of a recovery are starting to emerge following the company's better than expected fiscal Q2 results, Ellis tells investors in a research note.
05/17/19
CHLM
05/17/19
NO CHANGE
Target $50
CHLM
Buy
Applied Materials price target raised to $50 from $44 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for Applied Materials to $50 from $44 and maintained a Buy rating following the company's Q3 results, saying the company outlined an expected return to growth in 2020. Schwab tells investors in a research note that while specific timing and magnitude of a recovery still lacks visibility, he is encouraged that estimate cuts appear to be over.
05/17/19
COWN
05/17/19
NO CHANGE
Target $53
COWN
Outperform
Applied Materials price target raised to $53 from $47 at Cowen
Cowen analyst Krish Sankar raised his price target on Applied Materials to $53 from $47 after the company reported in-line results for the April-end quarter and gave "better than feared" guidance for the July-end quarter, citing stable Semis demand and a healthy Services business. He noted that management's tone remained unchanged from a quarter ago, signaling no incremental signs of deterioration in conditions despite the fact that demand visibility remains limited. Sankar keeps an Outperform rating on Applied Materials shares.
05/15/19
05/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Westlake Chemical (WLK) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the stock's 49% decline over the past year has created an opportunity to gain exposure to two commodity cycles that are bottoming, ethylene and chloralkali. 2. Zillow (ZG, Z) upgraded to Buy from Neutral at Guggenheim with analyst Jake Fuller saying its recent results prove that demand for Offers "is real" and he expects the company's Offers business to surpass its ad business by Q4 and generate greater than $1B of revenue in its first full year. 3. Chevron (CVX) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Neil Mehta saying Chevron's cash flow profile has positively inflected with the production contribution and capital spending roll-off from the startup of both the Gorgon and Wheatstone LNG projects. 4. Hess Corp. (HES) upgraded to Equalweight from Underweight at Capital One with analyst Phillips Johnston saying he reviewed his model post Q1 earnings and "massively" overhauled his Guyana production estimates. 5. Applied Materials (AMAT) and Advanced Energy (AEIS) upgraded to Positive from Neutral at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BWA BorgWarner
$36.27

-0.375 (-1.02%)

02/13/19
GHSC
02/13/19
INITIATION
GHSC
Neutral
BorgWarner initiated with a Neutral at Seaport Global
01/28/19
BMOC
01/28/19
NO CHANGE
BMOC
BorgWarner, Gentherm, Visteon, Autolive price targets raised at BMO Capital
BMO Capital analyst Richard Carlso is turning more bullish on the auto and mobility equipment industry, saying the sentiment from the most recent CES, Detroit Auto Show, and GM's (GM) Capital Markets Day events has shifted his outlook from "cautious" to "cautiously optimistic". The analyst attributes the snap-back rally in the sector stocks' prices to increased optimism over the impact of lingering trade issues and outlooks from companies that have so far updated on their Q4 performance, all of which suggested that the 2018-end declines were overextended. Carlson is raising his price target on Autoliv (ALV) to $84 from $79, on Gentex (GNTX) to $27 from $24, on Aptiv (APTV) to $84 from $74, on Veoneer (VNE) to $41 from $36, on BorgWarner (BWA) to $49 from $44, and on Visteon (VC) to $91 from $84.
02/15/19
BARD
02/15/19
NO CHANGE
Target $47
BARD
Outperform
BorgWarner price target raised to $47, remains top pick at Baird
Baird analyst David Leiker raised his price target on BorgWarner to $47 from $41 after the company reported in-line Q4 results. The analyst said it remains one of the best ideas on his list and noted valuation is currently near cycle lows. He sees improved near-term performance, significant re-rating potential given its valuation, and an attractive long-term growth profile. Leiker reiterated his Outperform rating on BorgWarner shares.
01/07/19
MSCO
01/07/19
NO CHANGE
MSCO
Morgan Stanley sees most, if not all, auto suppliers guiding below consensus
Ahead of the Detroit auto show, Morgan Stanley analyst Armintas Sinkevicius said he expects that most, if not all, auto suppliers will provide 2019 guidance that is lower than consensus. He sees the most downside risk to Visteon (VC) and Adient (ADNT), estimating that they may guide adjusted EBITDA 6.4% and 5.0% below consensus, respectively. Not everyone will provide guidance at the show, as American Axle (AXL) and Delphi Technologies (DLPH) gave guidance with Q3 earnings and Aptiv (APTV) and BorgWarner (BWA) plan to wait for Q4 earnings, added Sinkevicius. He estimates that, on average, the auto suppliers will guide to 1.5% revenue growth and -25 bps of margin contraction in 2019, adding that his concern is that the guidance provided at Detroit may not sufficiently de-risk figures. Others in the space include Lear (LEA), Tenneco (TEN) and Magna (MGA).
SCHW Charles Schwab
$43.21

-0.94 (-2.13%)

01/22/19
MSCO
01/22/19
NO CHANGE
Target $57
MSCO
Overweight
Charles Schwab target raised to $57 ahead of winter update at Morgan Stanley
Morgan Stanley analyst Michael Cyprys said he has increased conviction in Charles Schwab (SCHW) shares after the company saw stronger organic deposit growth and broadly strong underlying growth metrics in Q4. He expects Charles Schwab to provide2019 guidance at the company's upcoming Winter Update on February 5 that should meet consensus expectations, but he also expects Schwab to beat those expectations over the course of 2019, as they havve done in prior years. He also expects Charles Schwab to give "more rational" pricing commentary this late in the cycle, which should support the stock and peers TD Ameritrade (AMTD) and E-Trade (ETFC), Cyprys tells investors. He raised his price target on Charles Schwab shares to $57 from $55 ahead of the update call and keeps an Overweight rating on the stock.
01/29/19
MSCO
01/29/19
NO CHANGE
MSCO
Overweight
Morgan Stanley sees 'more to come' from discount brokers after strong Q4
Morgan Stanley analyst Michael Cyprys said the "strong" Q4 earnings reports from Charles Schwab (SCHW), E-Trade (ETFC) and TD Ameritrade (AMTD) showed that the discount brokers can grow revenues in a volatile, late-cycle backdrop. He increased his 2020 top-line estimates across the group, citing expectations for higher net interest margins and higher cash balances. Cyprys, who said the valuations in the group remain compelling on both an absolute and relative basis, keeps Overweight ratings on all three stocks mentioned. He raised his price target on Charles Schwab to $57 from $55, on E-Trade to $62 from $61 and on TD Ameritrade to $64 from $59.
02/20/19
02/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CVS Health (CVS) downgraded to Market Perform from Outperform at Wells Fargo with analyst Peter Costa citing its "continued failure" to stabilize its existing businesses, particularly the long-term care business, after two years of pressure. 2. Southwest (LUV) downgraded to Sell from Neutral at Goldman Sachs with analyst Catherine O'Brien saying Southwest's fiscal 2019 pretax margin will decline 60 basis points due to the dilutive impact of its new Hawaii flying and unit cost ex-fuel pressures. 3. Charles Schwab (SCHW) downgraded to Sell from Neutral at UBS, while E-Trade (ETFC) was downgraded to Neutral from Buy. 4. Palo Alto Networks (PANW) downgraded to Hold from Buy at Gabelli with analyst Hendi Susanto citing valuation. 5. Teva (TEVA) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying her investment thesis is "broken" after Teva's "disappointing 2019 guidance and cautious longer-term outlook." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/20/19
UBSW
02/20/19
DOWNGRADE
Target $42
UBSW
Sell
Charles Schwab downgraded to Sell from Neutral at UBS
UBS analyst Brennan Hawken downgraded Charles Schwab to Sell and lowered his price target for the shares to $42 from $48. The analyst sees revenue headwinds at the same time as risk to upward pressure on expenses. This will lead to earnings and multiple compression, Hawken tells investors in a research note. The analyst believes Schwab's revenue guidance, which assumes a mid-year rate hike and higher daily average revenue trades, is aggressive against the current backdrop. Expectations may be too high and could put the stock at risk, particularly since buybacks are likely not enough to "cushion the blow to the growth story," Hawken contends.
REGN Regeneron
$304.81

-4.69 (-1.52%)

05/08/19
BMOC
05/08/19
NO CHANGE
Target $375
BMOC
Market Perform
Regeneron price target lowered to $375 from $412 at BMO Capital
BMO Capital analyst Matthew Luchini lowered his price target on Regeneron (REGN) to $375 after its "uninspiring" Q1 driven by higher R&D costs and lower collaboration revenue with Sanofi (SNY). The analyst notes that while the company's Dupixent is "showing progress" and Eylea's 8% revenue growth is a positive, he is also concerned with higher discounting for the latter along with the potential for a more competitive vascular endothelial growth factor, or VEGF, landscape. Luchini keeps his Market Perform rating on Regeneron.
05/16/19
JPMS
05/16/19
NO CHANGE
Target $395
JPMS
Neutral
Regeneron selloff brings improved risk/reward, says JPMorgan
JPMorgan analyst Cory Kasimov keeps a Neutral rating on shares of Regeneron Pharmaceuticals buy says the stock's risk/reward is improved following the recent sharp pullback. The analyst adds that feedback from five doctors supports his above-consensus estimates for Dupixent. Kasimov currently models peak sales north of $7B across atopic dermatitis, asthma, and nasal polyps in the U.S. and Europe, "with everything else left as upside." Every $1B in total Dupixent revenue results in a $20 impact to the stock's fair valuation, the analyst tells investors in a research note titled "Dupi...How Big Is Big?"
05/13/19
CANT
05/13/19
NO CHANGE
Target $405
CANT
Neutral
Regeneron price target lowered to $405 from $441 at Cantor Fitzgerald
Cantor Fitzgerald analyst Regeneron Pharmaceuticals (REGN) to $405 from $441 saying the company's expenses are tracking higher than his projections. Further, he thinks investor concerns about Novartis' (NVS) brolucizumab approval in eye and increased atopic dermatitis competition remain headwinds for share upside. The analyst reiterates a Neutral rating on Regeneron following its Q1 results.
05/08/19
ADAM
05/08/19
NO CHANGE
Target $353
ADAM
Hold
Regeneron price target cut to $353 from $408 at Canaccord
Canaccord analyst John Newman cut his price target for Regeneron to $353 from $408 and maintained a Hold rating following the company's Q1 results, saying R&D expense and 2019 guidance surprised investors, although he thinks more R&D investment is beneficial in the long-term, despite short-term pains. However, the increase in R&D spending may persist due to ongoing early pipeline programs, Libtayo development costs, higher clinical manufacturing costs, and higher headcount, Newman tells investors in a research note.
TPR Tapestry
$30.78

-0.56 (-1.79%)

05/09/19
STPT
05/09/19
UPGRADE
STPT
Buy
Tapestry upgraded to Buy from Hold at Standpoint Research
05/06/19
PIPR
05/06/19
NO CHANGE
Target $39
PIPR
Overweight
Tapestry shares near 'trough multiples' with 4% yield, says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says investor sentiment on Tapestry is negative and that while she does have "emerging questions on the multi-year positioning of the accessible luxury category," the shares are near "trough multiples" with a dividend yield of greater than 4%. She believes Tapestry will maintain positive double-digit earnings growth for fiscal 2020 and keeps an Overweight rating on the shares with a $39 price target. Further, Murphy thinks the company's fiscal Q3 results will be in-line with estimates.
05/06/19
BARD
05/06/19
NO CHANGE
Target $43
BARD
Outperform
Tapestry facing 'tricky setup' ahead of earnings, says Baird
Baird analyst Mark Altschwager said he sees Tapestry facing a "tricky setup" ahead of its earnings report, stating that the company's conservative guidance is offset by risk to Q3 comp sales and gross margin estimates, especially at the Kate Spade brand. However, he also believes a lot of negativity is already priced in and continue to see an attractive risk/reward for investors who are "willing to let the story play out" over the next six to twelve months. Altschwager keeps an Outperform rating and $43 price target on Tapestry shares.
04/23/19
04/23/19
DOWNGRADE

Mixed
Tapestry downgraded to Mixed following checks at OTR Global
As previously reported, OTR Global downgraded Tapestry to Mixed from Positive. The firm's checks indicate Q3 outlet sales and traffic were hurt by the late Easter and cold spring.
TTWO Take-Two
$106.76

-0.81 (-0.75%)

05/15/19
GSCO
05/15/19
NO CHANGE
GSCO
Goldman says report of Epic store unlock in China positive for Take-Two, Ubisoft
After a report citing Chinese news site Techweb claimed that the Epic games store has been unlocked in China, Goldman Sachs analyst Michael Ng said he views the news as positive for video game publishers, notably Take-Two (TTWO) and Ubisoft (UBSFY) given the launches of Borderlands 3 and The Outer Worlds by the former and The Division 2 and Ghost Recon Breakpoint for the latter. Ng has a Buy rating on Take-Two and a Neutral rating on Ubisoft.
05/17/19
BMOC
05/17/19
NO CHANGE
Target $95
BMOC
Underperform
Take-Two price target raised to $95 from $80 at BMO Capital
BMO Capital analyst Gerrick Johnson raised his price target on Take-Two to $95 after its above-consensus Q4 earnings, saying that while net bookings missed expectations, lower-than-expected internal royalties drove the bottom-line beat. The analyst notes that the company's core titles like NBA 2K and GTA Online have shown continued strength, but also views the performance of Red Dead Redemption 2 as disappointing. Johnson also keeps his Underperform rating on the stock, warning that monetization of Red Dead Redemption could fall below current expectations with added concern about the potential changes in the video game industry driving lower valuation multiples.
05/14/19
PIPR
05/14/19
NO CHANGE
Target $114
PIPR
Overweight
Take-Two RDR monetization to pick up in 2020, says Piper Jaffray
Piper Jaffray analyst Michael Olson notes that Red Dead Online has officially come out of beta with a slew of new content updates, including a co-op story line, which he believes is similar to the first GTA Online "heist" missions. Some investors have grown frustrated with the lack of monetization of RDR Online so far, but he notes that GTA Online was essentially unplayable for its first 6 months before hitting an inflection point with a "heists" update. Olson believes the just-released update for Red Dead Online has the potential for a similar impact. Expecting RDR monetization to pick up in 2020, the analyst reiterates an Overweight rating and $114 price target on the shares.

TODAY'S FREE FLY STORIES

GE

General Electric

$10.04

-0.2 (-1.95%)

21:05
06/17/19
06/17
21:05
06/17/19
21:05
Periodicals
General Electric to cut another 450 jobs in Switzerland, Reuters says »

General Electric will lay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$86.25

-1.52 (-1.73%)

20:00
06/17/19
06/17
20:00
06/17/19
20:00
Hot Stocks
Arthur J. Gallagher acquires P2 Group, terms not stated »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

AGLNF

AGL Energy

$0.00

(0.00%)

19:28
06/17/19
06/17
19:28
06/17/19
19:28
Upgrade
AGL Energy rating change at Macquarie »

AGL Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

, RUN

Sunrun

$17.09

0.64 (3.89%)

19:02
06/17/19
06/17
19:02
06/17/19
19:02
Upgrade
SunPower, Sunrun, SolarEdge rating change at Goldman Sachs »

SunPower, Sunrun upgraded…

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

SEDG

SolarEdge

$56.58

0.09 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

, PHAS

PhaseBio

$12.25

0.74 (6.43%)

18:48
06/17/19
06/17
18:48
06/17/19
18:48
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: MoneyGram (MGI)…

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

PHAS

PhaseBio

$12.25

0.74 (6.43%)

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

STLD

Steel Dynamics

$26.23

-0.19 (-0.72%)

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

CALA

Calithera Biosciences

$5.87

0.64 (12.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 18

    Jun

  • 19

    Jun

AAPL

Apple

$193.90

1.06 (0.55%)

18:44
06/17/19
06/17
18:44
06/17/19
18:44
Periodicals
Apple's tvOS 13 beta 2 includes Picture-in-Picture support, 9to5Mac reports »

Apple's tvOS 13 beta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$56.58

0.09 (0.16%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SolarEdge rating change at Goldman Sachs »

SolarEdge upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUN

Sunrun

$17.09

0.64 (3.89%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
Sunrun rating change at Goldman Sachs »

Sunrun upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SunPower rating change at Goldman Sachs »

SunPower upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

18:32
06/17/19
06/17
18:32
06/17/19
18:32
Hot Stocks
Bluescope Steel cuts FY19 EBIT growth view to up 6% from up 10% »

BlueScope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$147.54

-1.25 (-0.84%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Hot Stocks
International Flavors CEO: We have planned for Brexit and China is benign for us »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.63

-0.65 (-1.12%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Periodicals
Senator aims to bar Huawei from seeking damages in patent courts, Reuters says »

U.S. Senator Marco Rubio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:12
06/17/19
06/17
18:12
06/17/19
18:12
Hot Stocks
Breaking Hot Stocks news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$39.00

1.46 (3.89%)

18:04
06/17/19
06/17
18:04
06/17/19
18:04
Hot Stocks
Dish launches OnTech Smart Services »

Dish announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.30

-0.06 (-0.19%)

18:03
06/17/19
06/17
18:03
06/17/19
18:03
Hot Stocks
AT&T wins 24 GHz spectrum following FCC Auction 102 »

AT&T is the winning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:02
06/17/19
06/17
18:02
06/17/19
18:02
Syndicate
Biohaven Pharmaceutical offers to sell $300M in common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSM

Versum Materials

$51.42

0.01 (0.02%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

18:01
06/17/19
06/17
18:01
06/17/19
18:01
Hot Stocks
Versum Materials shareholders approve merger with Merck KGaA »

Versum Materials (VSM)…

VSM

Versum Materials

$51.42

0.01 (0.02%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

VLO

Valero

$76.93

0.19 (0.25%)

18:00
06/17/19
06/17
18:00
06/17/19
18:00
Periodicals
Valero restarting Port Arthur, Texas refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

VLO

Valero

$76.93

0.19 (0.25%)

17:59
06/17/19
06/17
17:59
06/17/19
17:59
Periodicals
Valero restarting Meraux, Louisiana refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

17:44
06/17/19
06/17
17:44
06/17/19
17:44
Hot Stocks
MoneyGram spikes almost 140% after blockchain company Ripple investment »

Money transfer company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

JKS

JinkoSolar

$22.59

-2.08 (-8.43%)

17:37
06/17/19
06/17
17:37
06/17/19
17:37
Downgrade
JinkoSolar rating change at UBS »

JinkoSolar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

FCEL

FuelCell

$0.33

-0.0231 (-6.56%)

17:26
06/17/19
06/17
17:26
06/17/19
17:26
Earnings
FuelCell reports Q2 ($2.06), consensus ($2.24) »

Reports Q2 revenue $9.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

17:25
06/17/19
06/17
17:25
06/17/19
17:25
Hot Stocks
Breaking Hot Stocks news story on Rockwell Medical »

Rockwell Medical down 21%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

VRS

Verso

$17.91

-0.24 (-1.32%)

17:21
06/17/19
06/17
17:21
06/17/19
17:21
Hot Stocks
Verso adopts limited duration stockholder rights plan »

Verso announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHVKF

China Vanke Co

$0.00

(0.00%)

17:19
06/17/19
06/17
17:19
06/17/19
17:19
Downgrade
China Vanke Co rating change at Morgan Stanley »

China Vanke Co downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.